Nutex Health Inc. (NUTX) stock
NUTXNasdaqServices-Business Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3069% below fair value
$173.67+2.26 (+1.32%)
Close on Nov 13, 2026Market cap $1.19BP/E 7.4Yield –
Nutex Health operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Nutex Health's operating cash flow for the twelve months ending Sep 30, 2026 was $258.45M, up 45.4% year over year. For fiscal 2025 it was $248.13M, up 971.7% from the year before. Over ten years it grew 136.7% a year on average. The highest annual figure on record is $248.13M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $248.13M | +971.7% |
| FY2024 | Dec 31, 2024 | $23.15M | +1741.9% |
| FY2023 | Dec 31, 2023 | $1.26M | -97.5% |
| FY2022 | Dec 31, 2022 | $50.61M | -70.8% |
| FY2021 | Dec 31, 2021 | $173.43M | +100.1% |
| FY2020 | Dec 31, 2020 | $86.67M | – |
| FY2019 | Dec 31, 2019 | -$4.04M | – |
| FY2018 | Dec 31, 2018 | -$480.05K | – |
| FY2017 | Dec 31, 2017 | -$714.62K | – |
| FY2016 | Dec 31, 2016 | -$274.22K | -710.6% |
| FY2015 | Dec 31, 2015 | $44.91K | -71.8% |
| FY2014 | Dec 31, 2014 | $159.20K | – |
| FY2013 | Dec 31, 2013 | -$183.15K | – |
| FY2012 | Dec 31, 2012 | -$518.69K | – |
| FY2011 | Dec 31, 2011 | -$659.14K | – |
| FY2010 | Dec 31, 2010 | -$1.64M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $78.35M | -21.3% |
| Q2 FY2026 | Jun 30, 2026 | $34.20M | +25.5% |
| Q1 FY2026 | Mar 31, 2026 | $75.52M | +48.2% |
| Q4 FY2025 | Dec 31, 2025 | $70.39M | +130250.0% |
| Q3 FY2025 | Sep 30, 2025 | $99.51M | +1366.0% |
| Q2 FY2025 | Jun 30, 2025 | $27.26M | +105.6% |
| Q1 FY2025 | Mar 31, 2025 | $50.97M | +1570.4% |
| Q4 FY2024 | Dec 31, 2024 | $54.00K | – |
| Q3 FY2024 | Sep 30, 2024 | $6.79M | +244.9% |
| Q2 FY2024 | Jun 30, 2024 | $13.26M | +107538.6% |
| Q1 FY2024 | Mar 31, 2024 | $3.05M | +190.0% |
| Q4 FY2023 | Dec 31, 2023 | -$1.78M | -139.4% |
| Q3 FY2023 | Sep 30, 2023 | $1.97M | – |
| Q2 FY2023 | Jun 30, 2023 | $12.32K | -99.9% |
| Q1 FY2023 | Mar 31, 2023 | $1.05M | -97.1% |
| Q4 FY2022 | Dec 31, 2022 | $4.51M | -90.3% |
| Q3 FY2022 | Sep 30, 2022 | -$7.30M | -130.1% |
| Q2 FY2022 | Jun 30, 2022 | $17.66M | -82.9% |
| Q1 FY2022 | Mar 31, 2022 | $35.74M | – |
| Q4 FY2021 | Dec 31, 2021 | $46.42M | -47.4% |
| Q3 FY2021 | Sep 30, 2021 | $24.25M | – |
| Q2 FY2021 | Jun 30, 2021 | $103.32M | – |
| Q1 FY2021 | Mar 31, 2021 | -$567.06K | – |
| Q4 FY2020 | Dec 31, 2020 | $88.23M | – |
| Q3 FY2020 | Sep 30, 2020 | -$189.77K | – |
| Q2 FY2020 | Jun 30, 2020 | -$495.24K | – |
| Q1 FY2020 | Mar 31, 2020 | -$872.99K | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.49M | -740.4% |
| Q3 FY2019 | Sep 30, 2019 | -$861.76K | – |
| Q2 FY2019 | Jun 30, 2019 | -$823.78K | – |
| Q1 FY2019 | Mar 31, 2019 | -$864.81K | – |
| Q4 FY2018 | Dec 31, 2018 | $232.72K | – |
| Q3 FY2018 | Sep 30, 2018 | -$220.74K | – |
| Q2 FY2018 | Jun 30, 2018 | -$218.83K | – |
| Q1 FY2018 | Mar 31, 2018 | -$273.20K | -1281.1% |
| Q2 FY2017 | Jun 30, 2017 | -$242.98K | – |
| Q1 FY2017 | Mar 31, 2017 | -$124.72K | – |
| Q4 FY2016 | Dec 31, 2016 | -$73.65K | – |
| Q3 FY2016 | Sep 30, 2016 | $23.13K | – |
See a number that looks wrong?